MyEpiPen® Patient Support Program
Australia’s 35,000-member EpiClub® program has been revamped and rebranded by Viatris (formerly Mylan) as the MyEpiPen® Patient Support Program.
Benefits for patients who join MyEpiPen® include:
- Free EpiPen® trainer devices
- Email and SMS reminder service for patients before their EpiPen® adrenaline (epinephrine) Auto-Injector devices expire.
- ‘How to use’ cards to keep at home and share with others.
- Video explainers in 26 languages that are appropriate for new patients and as refreshers for experienced patients.
- Real-world patient videos in which parents and patients describe their experiences with using EpiPen® for first aid.
- Evidence-based information to help people understand more about anaphylaxis and their EpiPen® Auto-Injectors.
- Regular newsletters to keep patients up to date with relevant information.
- Evidence-based information to help people understand more about anaphylaxis and their EpiPen® Auto-Injectors, with links to ASCIA anaphylaxis resources, such as the EpiPen® version of the ASCIA Action Plan for Anaphylaxis.
- MyEpiPen® Welcome Kits which include the bag tag and wallet card that were developed by ASCIA after liaising with the team at Viatris.
To access MyEpiPen® go to https://www.myepipen.com.au/
Patients in New Zealand are currently on a separate EpiClub® NZ site, and will transition to MyEpiPen® in the near future.
If you are registered for the ASCIA 2021 Virtual Conference, you can attend the following Viatris sponsored sessions, as shown on page 10 of the ASCIA 2021 Conference Program Book https://ascia2021.com/program.php:
Thursday 2nd September, 9-9.45 AEST, ‘Risk Multipliers for Anaphylaxis’ presented by Prof Pete Smith.
Friday 3rd September 9-9.45 AEST, ‘Classic Hayfever, Local Allergic Rhinitis and Nasal Hyper-Reactivity: Sorting out Nasal Symptoms and Treatments’ presented by Prof Richard Harvey.
If you are not yet registered for the ASCIA 2021 Virtual Conference go to https://ascia2021.com/registration.php